Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anupam Batra

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Expert Opinion on Emerging Drugs|November 14, 2018
Emerging cell cycle inhibitors for treating metastatic castration-resistant prostate cancerAnupam Batra, Eric Winquist
Current Oncology (Toronto, Ont.)|February 23, 2024
Contemporary Systemic Therapy Intensification for Prostate Cancer: A Review for General Practitioners in OncologyAnupam Batra, Daniel Glick, Mario Valdes
Frontiers in Rehabilitation Sciences|October 20, 2025
The impact of second-generation androgen receptor pathway inhibitors on skeletal muscle morphology and strategies to mitigate their effects in prostate cancer patientsSarah Edwards, Tea Lulic-Kuryllo, Anupam Batra
Canadian Family Physician Medecin De Famille Canadien|April 18, 2023
Razan AlJasem, Layth Mula-Hussain, Anupam Batra, et al.
Canadian Family Physician Medecin De Famille Canadien|April 18, 2023
Radiation-induced cognitive impairment in older adultsRazan AlJasem, Layth Mula-Hussain, Anupam Batra, et al.
Current Oncology (Toronto, Ont.)|August 28, 2024
Contemporary Management of Renal Cell Carcinoma: A Review for General Practitioners in OncologyAnish Tejura, Ricardo Fernandes, Stacey Hubay, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|July 27, 2019
Early experience with chemotherapy intensification for poor-prognosis metastatic germ cell cancer and unfavorable tumor marker declineAnupam Batra, Scott Ernst, Kylea Potvin, et al.
The Biochemical Journal|March 10, 2017
Binding and inhibition of the ternary complex factor Elk-4/Sap1 by the adapter protein Dok-4Erika Hooker, Cindy Baldwin, Victoria Roodman, et al.
Clinical Lung Cancer|January 30, 2020
Predictors of Survival Benefit From Immune Checkpoint Inhibitors in Patients With Advanced Non-small-cell Lung Cancer: A Systematic Review and Meta-analysisJacques Raphael, Anupam Batra, Gabriel Boldt, et al.
BMC Cancer|June 22, 2014
Expression of integrin α3β1 and cyclooxygenase-2 (COX2) are positively correlated in human breast cancerAnshu Aggarwal, Rami N Al-Rohil, Anupam Batra, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Expert Opinion on Emerging Drugs|November 14, 2018
Emerging cell cycle inhibitors for treating metastatic castration-resistant prostate cancerAnupam Batra, Eric Winquist
Current Oncology (Toronto, Ont.)|February 23, 2024
Contemporary Systemic Therapy Intensification for Prostate Cancer: A Review for General Practitioners in OncologyAnupam Batra, Daniel Glick, Mario Valdes
Frontiers in Rehabilitation Sciences|October 20, 2025
The impact of second-generation androgen receptor pathway inhibitors on skeletal muscle morphology and strategies to mitigate their effects in prostate cancer patientsSarah Edwards, Tea Lulic-Kuryllo, Anupam Batra
Canadian Family Physician Medecin De Famille Canadien|April 18, 2023
Razan AlJasem, Layth Mula-Hussain, Anupam Batra, et al.
Canadian Family Physician Medecin De Famille Canadien|April 18, 2023
Radiation-induced cognitive impairment in older adultsRazan AlJasem, Layth Mula-Hussain, Anupam Batra, et al.
Current Oncology (Toronto, Ont.)|August 28, 2024
Contemporary Management of Renal Cell Carcinoma: A Review for General Practitioners in OncologyAnish Tejura, Ricardo Fernandes, Stacey Hubay, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|July 27, 2019
Early experience with chemotherapy intensification for poor-prognosis metastatic germ cell cancer and unfavorable tumor marker declineAnupam Batra, Scott Ernst, Kylea Potvin, et al.
The Biochemical Journal|March 10, 2017
Binding and inhibition of the ternary complex factor Elk-4/Sap1 by the adapter protein Dok-4Erika Hooker, Cindy Baldwin, Victoria Roodman, et al.
Clinical Lung Cancer|January 30, 2020
Predictors of Survival Benefit From Immune Checkpoint Inhibitors in Patients With Advanced Non-small-cell Lung Cancer: A Systematic Review and Meta-analysisJacques Raphael, Anupam Batra, Gabriel Boldt, et al.
BMC Cancer|June 22, 2014
Expression of integrin α3β1 and cyclooxygenase-2 (COX2) are positively correlated in human breast cancerAnshu Aggarwal, Rami N Al-Rohil, Anupam Batra, et al.
Pageof 2